Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease
NEJM Evidence · 28.10.2025 · 4 (11)
DOI: 10.1056/evidoa2500158 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift NEJM Evidence, erschienen am 28.10.2025. Verfasst von Katja Vu Bartholdy und 28 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, Unive…. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen.
- Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen.
- Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen.
- Department of Nephrology, Copenhagen University Hospital - Rigshospitalet, Copenhagen.
- Department of Nephrology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen.
Zitieren
APA
Bartholdy, K. V., Johansen, N. D., Skaarup, K. G., Modin, D., Landler, N., Langhoff, A. F., Ottosen, C. I., Espersen, C., Dons, M., Borchsenius, J. I. M., Davodian, L. W., Lassen, M. H., Davidovski, F. S., Jensen, A. M. R., Sengeløv, M., Christensen, J., Schou, M., Feldt-Rasmussen, B., Jensen, J., …, & Biering-Sørensen, T. (2025). Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease. NEJM Evidence, 4(11). https://doi.org/10.1056/evidoa2500158
Vancouver
Bartholdy KV, Johansen ND, Skaarup KG, Modin D, Landler N, Langhoff AF, et al. Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease. NEJM Evidence. 2025;4(11). doi:10.1056/evidoa2500158
BibTeX
@article{Bartholdy2025,
author = {Bartholdy, Katja Vu and Johansen, Niklas Dyrby and Skaarup, Kristoffer Grundtvig and Modin, Daniel and Landler, Nino and Langhoff, Adam Femerling and Ottosen, Camilla Ikast and Espersen, Caroline and Dons, Maria and Borchsenius, Julie Inge Marie and Davodian, Lise Witten and Lassen, Mats Højbjerg and Davidovski, Filip Soeskov and Jensen, Anne Marie Reimer and Sengeløv, Morten and Christensen, Jacob and Schou, Morten and Feldt-Rasmussen, Bo and Jensen, Jesper and Bressendorff, Iain and Persson, Frederik and Rossing, Peter and Køber, Lars and Zannad, Faiez and Vaduganathan, Muthiah and Solomon, Scott and Haynes, Richard and Hansen, Ditte and Biering-Sørensen, Tor},
title = {Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease},
journal = {NEJM Evidence},
year = {2025},
volume = {4},
number = {11},
doi = {10.1056/evidoa2500158}
}
EUVIMED